Predictive factors of adherence to an association of glucosamine sulfate, copper, and ginger extracts in patients with symptomatic osteoarthritis: a prospective open-label French noninterventional study (the PREDOA study)

References

• Zhang Y, Jordan JM. Epidemiology of osteoarthritis. Clin Geriatr Med. 2010;26:355–369. doi:10.1016/j.cger.2010.03.00120699159
   PubMed Web of Science ®Google Scholar
• Jordan KM, Arden NK, Doherty M. Standing Committee for International Clinical Studies Including Therapeutic Trials ESCISIT. EULAR recommendations 2003: an evidence based approach to the management of knee osteoarthritis: report of a task force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis. 2003;62:114555.
   Web of Science ®Google Scholar
• Zhang W, Moskowitz RW, Nuki G, et al. OARSI recommendations for the management of hip and knee osteoarthritis, Part I: critical appraisal of existing treatment guidelines and systematic review of current research evidence. Osteoarthritis Cartilage. 2007;15:981. doi:10.1016/j.joca.2007.06.01417719803
   PubMed Web of Science ®Google Scholar
• Zhang W, Doherty M, Leeb BF, et al. EULAR evidence based recommendations for the management of hand osteoarthritis: report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis. 2007;66:377–388.17046965
   PubMed Web of Science ®Google Scholar
• Zhang W, Moskowitz RW, Nuki G, et al. OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence based, expert consensus guidelines. Osteoarthritis Cartilage. 2008;16:137–162. doi:10.1016/j.joca.2008.02.01318279766
   PubMed Web of Science ®Google Scholar
• Zhang W, Nuki G, Moskowitz RW, et al. OARSI recommendations for the management of hip and knee osteoarthritis: Part III: changes in evidence following systematic cumulative update of research published through January 2009. Osteoarthritis Cartilage. 2010;18:476–499. doi:10.1016/j.joca.2009.11.01420170770
   PubMed Web of Science ®Google Scholar
• Henrotin Y, Lambert C, Couchourel D, Ripoll C, Chiotelli E. Nutraceuticals: do they represent a new era in the management of osteoarthritis? - A narrative review from the lessons taken with five products. Osteoarthritis Cartilage. 2011;19:1–21. doi:10.1016/j.joca.2010.10.01721035558
   PubMed Web of Science ®Google Scholar
• Liu X, Machado GC, Eyles JP, Ravi V, Hunter DJ. Dietary supplements for treating osteoarthritis: a systematic review and meta-analysis. Br J Sports Med. 2018;52(3):167–175. doi:10.1136/bjsports-2016-09733329018060
   PubMed Web of Science ®Google Scholar
• Wang A, Leong DJ, Cardoso L, Sun HB. Nutraceuticals and osteoarthritis pain. Pharmacol Ther. 2018;187:167–179. doi:10.1016/j.pharmthera.2018.02.01529481810
   PubMed Web of Science ®Google Scholar
• Dougados M. Symptomatic slow acting drugs for osteoarthritis: what are the facts. Joint Bone Spine. 2006;73:606–609. doi:10.1016/j.jbspin.2006.09.00817126058
   PubMed Web of Science ®Google Scholar
• Forman JP, Rimm EB, Curhan GC. Frequency of analgesic use and risk of hypertension among men. Arch Intern Med. 2007;167(4):394–399. doi:10.1001/archinte.167.4.39417325302
   PubMed Web of Science ®Google Scholar
• Sudano I, Flammer AJ, Roas S, Enseleit F, Noll G, Ruschitzka F. Nonsteroidal antiinflammatory drugs, acetaminophen, and hypertension. Curr Hypertens Rep. 2012;14:304–309. doi:10.1007/s11906-012-0274-722610476
   PubMed Web of Science ®Google Scholar
• Lanas A, Tornero J, Zamorano JL. Assessment of gastrointestinal and cardiovascular risk in patients with osteoarthritis who require NSAIDs: the LOGICA study. Ann Rheum Dis. 2010;69:1453–1458. doi:10.1136/ard.2009.12316620498210
   PubMed Web of Science ®Google Scholar
• McAlindon DM, La Valley MP, Gulin JP, Felson DT. Glucosamine and chondroitin for treatment of osteoarthritis. A systematic quality assessment and metaanalysis. JAMA. 2000;283:1469–1475.10732937
   PubMed Web of Science ®Google Scholar
• Lee YH, Woo JH, Choi SJ, Ji JD, Song GG. Effect of glucosamine or chondroitin sulfate on the osteoarthritis progression: a meta-analysis. Rheumatol Int. 2010;30:357–363. doi:10.1007/s00296-009-0969-519544061
   PubMed Web of Science ®Google Scholar
• Black C, Clar C, Henderson R, et al. The clinical effectiveness of glucosamine and chondroitin supplements in slowing or arresting progression of osteoarthritis of the knee: a systematic review and economic evaluation. Health Technol Assess. 2009;13:1–148. doi:10.3310/hta13520
   PubMed Web of Science ®Google Scholar
• Chevalier X, Conrozier T. Access to highly purified chondroitin sulfate for appropriate treatment of osteoarthritis: a review. Med Access Point Care. 2017;1(1):e134–e144. doi:10.5301/maapoc.0000022
   Google Scholar
• Bruyère O, Altman RD, Reginster JY. Efficacy and safety of glucosamine sulfate in the management of osteoarthritis: evidence from real-life setting trials and surveys. Semin Arthritis Rheum. 2016;45(4 Suppl):S12–S17. doi:10.1016/j.semarthrit.2015.11.01126806187
   PubMed Web of Science ®Google Scholar
• Simental-Mendía M, Sánchez-García A, Vilchez-Cavazos F, Acosta-Olivo CA, Peña-Martínez VM, Simental-Mendía LE. Effect of glucosamine and chondroitin sulfate in symptomatic knee osteoarthritis: a systematic review and meta-analysis of randomized placebo-controlled trials. Rheumatol Int. 2018;38(8):1413–1428. doi:10.1007/s00296-018-4077-229947998
   PubMed Web of Science ®Google Scholar
• Kahan A, Uebelhart D, De Vathaire F, Delmas PD, Reginster J-Y. Long-term effects of chondroitins 4 and 6 sulfate on knee osteoarthritis: the study on osteoarthritis progression prevention, a two-year, randomized, double-blind, placebo-controlled trial. Arthritis Rheum. 2009;60:524–3340. doi:10.1002/art.2425519180484
   PubMed Web of Science ®Google Scholar
• Reginster JY, Deroisy R, Rovati LC, et al. Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial. Lancet. 2001;357:251–256. doi:10.1016/S0140-6736(00)03610-211214126
   PubMed Web of Science ®Google Scholar
• Pavelka K, Gatterova J, Olejarova M, et al. Glucosamine sulfate use and delay of progression of knee osteoarthritis: a 3-year, randomized, placebo-controlled, double-blind study. Arch Intern Med. 2002;162:2113–2123. doi:10.1001/archinte.162.18.211312374520
   PubMed Web of Science ®Google Scholar
• Shen CL, Hong KJ, Kim SW. Comparative effects of ginger root (Zingiber officinale Rosc.) on the production of inflammatory mediators in normal and osteoarthrotic sow chondrocytes. J Med Food. 2005;8:149–153. doi:10.1089/jmf.2005.8.14916117605
   PubMed Web of Science ®Google Scholar
• Altman RD1, Marcussen KC. Effects of a ginger extract on knee pain in patients with osteoarthritis. Arthritis Rheum. 2001;44(11):2531–2538.11710709
   PubMed Web of Science ®Google Scholar
• Bartels EM, Folmer VN, Bliddal H, et al. Efficacy and safety of ginger in osteoarthritis patients: a meta-analysis of randomized placebo-controlled trials. Osteoarthritis Cartilage. 2015;23(1):13–21. doi:10.1016/j.joca.2014.09.02425300574
   PubMed Web of Science ®Google Scholar
• Héraud F, Savineau C, Harmand MF. Copper modulation of extracellular matrix synthesis by human articular chondrocytes. Scand J Rheumatol. 2002;31:279–284.12455818
   PubMed Web of Science ®Google Scholar
• Rousset F, Grange L, Nguyen MVU, et al. Impact of the addition of ginger extract and copper sulphate to glucosamine sulphate on Il-1β-stimulated chondrocytes. J Rheum Dis Treat. 2016;2:038. doi:10.23937/2469-5726/1510038
   Google Scholar
• Poulet B, Staines KA. New developments in osteoarthritis and cartilage biology. Curr Opin Pharmacol. 2016;28:8–13. doi:10.1016/j.coph.2016.02.00926921602
   PubMed Web of Science ®Google Scholar
• Bruyère O, Cooper C, Pelletier JP, et al. An algorithm recommendation for the management of knee osteoarthritis in Europe and internationally: a report from a task force of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO). Semin Arthritis Rheum. 2014; pii:S0049-0172(14)00108-5. doi:10.1016/j.semarthrit.2014.05.014
   Web of Science ®Google Scholar
• Saliba L, Boisson L, Sallerin B, Laroche M, Despas F. The lack of adherence to antiosteoporotic drugs: crossing methods, the key to adherence measurement? Therapie. 2014;69(5):383–389. doi:10.2515/therapie/201402825269139
   PubMed Web of Science ®Google Scholar
• Murage MJ, Tongbram V, Feldman SR, et al. Medication adherence and persistence in patients with rheumatoid arthritis, psoriasis, and psoriatic arthritis: a systematic literature review. Patient Prefer Adherence. 2018;12:1483–1503. doi:10.2147/PPA.S16750830174415
   PubMed Web of Science ®Google Scholar
• Laba TL, Brien JA, Fransen M, Jan S. Patient preferences for adherence to treatment for osteoarthritis: the Medication Decisions in Osteoarthritis Study (MEDOS). BMC Musculoskelet Disord. 2013;61(14):160. doi:10.1186/1471-2474-14-160
   Web of Science ®Google Scholar
• Głuszko P, Stasiek M. Symptom-modifying effects of oral avocado/soybean unsaponifiables in routine treatment of knee osteoarthritis in Poland. An open, prospective observational study of patients adherent to a 6-month treatment. Reumatologia. 2016;54(5):217–226.27994265
   PubMedGoogle Scholar
• Sharma S, Roshi, Tandon VR, Mahajan A. A Study Evaluating Adherence and Compliance of Anti-rheumatic Drugs in Women Suffering from Rheumatoid Arthritis. J Clin Diagn Res. 2015;9(11):OC01–4. doi: 10.7860/JCDR/2015/15806.6729 1
   Google Scholar
• Sprouse AA, van Breemen RB. Pharmacokinetic interactions between drugs and botanical dietary supplements. Drug Metab Dispos. 2016;44(2):162–171. doi:10.1124/dmd.115.06690226438626
   PubMed Web of Science ®Google Scholar
• Hausner RS. The therapeutic and working alliances. J Am Psychoanal Assoc. 2000;48(1):155–187. doi:10.1177/0003065100048001100110808476
   PubMed Web of Science ®Google Scholar
• Martin DJ, Garske JP, Davis MK. Relation of the therapeutic alliance with outcome and other variables: a meta-analytic review. J Consult Clin Psychol. 2000;68(3):438–450.10883561
   PubMed Web of Science ®Google Scholar
• Benoit M, Pon J, Zimmermann MA. Comment évaluer la qualité de l’observance? L’Encéphale. 2009;Supplément 3:S87–S90. doi:10.1016/S0013-7006(09)75542-3
   Google Scholar
• Kermarrec S, Kabuth B, Bursztejn C, Guillemin F. French adaptation and validation of the helping alliance questionnaires for child, parents, and therapist. Can J Psychiatry. 2006;51(14):913–922. doi:10.1177/07067437060510140717249634
   PubMed Web of Science ®Google Scholar